Experts in evidence evaluation
for healthcare decision making
At Hereco, we specialise in providing high-quality, evidence-based consultancy services tailored to meet the unique needs of healthcare decision-makers. Our expert team is dedicated to delivering the most reliable data and comprehensive analysis, whether you’re evaluating clinical interventions, developing healthcare guidelines, assessing health technologies, or shaping health policy.
We understand that no two projects are alike, which is why we take a pragmatic and flexible approach, adapting our methodologies to suit the specific goals, scope, and challenges of each assignment.
A niche, professional consultancy based in Sydney, Australia, we work with government and non-profit organisations. Our aim is to improve the healthcare system by helping you make well-informed decisions that create lasting, positive changes in healthcare delivery and policy.
Health Technology Assessment (HTA)
We conduct in-depth HTA for medical devices, implanted prostheses, diagnostics, gene therapies, blood products, human tissue products, medical procedures and other health technologies. Our evaluations focus on understanding the comparative safety, clinical effectiveness, cost-effectiveness, and broader impact of new and existing technologies, helping you assess their value in terms of health outcomes, resource allocation, and policy development.
Evidence Reviews
We provide rigorous evidence evaluation from rapid overviews and evidence checks to comprehensive systematic reviews and meta-analyses. Our experienced team will work with you to define the research questions and to determine the most appropriate methodology to suit your needs and ensure that your evidence review is thorough, unbiased and methodologically sound. Our experience spans reviews of clinical evidence including treatment, diagnosis, prevention and etiology as well as health policy, economic evidence and evidence gaps.
Clinical Practice Guidelines
We assist in the development of clinical practice guidelines that are evidence-based, practical, and directly applicable to real-world healthcare settings. Hereco can assist with all aspects of clinical practice guideline development from short, focused guidance through to the development or updating of comprehensive guidelines using GRADE. By promoting consistency and best practices, we help improve patient care and support the standardisation of clinical practices across the healthcare system.
Health Economics
We undertake detailed evaluations of the cost-effectiveness and economic impact of healthcare interventions. Our experienced team can offer valuable insights using economic modelling and budget impact analysis, all underpinned by a solid understanding of clinical evidence. By evaluating the economic implications of new and existing treatments, we help support sustainable healthcare decision-making and ensure that interventions deliver value for money.
Directors
Sue Campbell, PhD
With over 20 years of experience in health technology assessment and evidence review, Sue Campbell excels at strategic and tailored approaches to evidence evaluation, which has earnt her a reputation as a trusted and insightful consultant. Working across diverse therapeutic areas and health technologies, including medical devices, diagnostic tests, surgically implanted prostheses, medical procedures and pharmaceuticals, Sue is passionate about the use of evidence and analysis to drive positive change in healthcare.
Samara Lewis, PhD
Samara Lewis is highly accomplished in evidence synthesis and evaluation, with over 15 years of experience in health technology assessment, systematic literature review, critical appraisal, economic analysis and budget impact analysis. Her pragmatic approach and commitment to working flexibly with clients ensures projects are delivered within budget and time constraints while meeting the policy needs of decision makers.
Jenny Ring, PhD
With over 13 years of experience as a consultant in health economics and outcomes research, Jenny Ring brings a wealth of expertise in evidence-based assessments, clinical practice guideline development and critical appraisal. She understands the evaluation of ‘real world’ evidence and the reality of working with incomplete datasets. Known for a commitment to excellence, Jenny has produced high-quality deliverables across a diverse range of therapeutic areas and health technologies.